Brain Tumor - Metastatic Active Not Recruiting Phase 2 Trials for Cabozantinib (DB08875)

IndicationStatusPhase
DBCOND0073320 (Brain Tumor - Metastatic)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02260531Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain MetastasesTreatment